Table of Contents
Washington University Experience | NEOPLASMS (METASTASES) | Microscopic | 93B3 Metastasis, breast & RadioRx (Case 93) PR 20X
Immunohistochemical prognostic and predictive biomarkers were performed. Progesterone receptor (PR) are both immunoreactive in tumor cells. HER-2 is minimally immunoreactive.
